Posterior reversible encephalopathy syndrome associated with deoxycoformycin and alemtuzumab.
| dc.contributor.author | Cooksley, Timothy J | |
| dc.contributor.author | Haji-Michael, Philip | |
| dc.date.accessioned | 2012-05-30T12:33:17Z | |
| dc.date.available | 2012-05-30T12:33:17Z | |
| dc.date.issued | 2011-09 | |
| dc.identifier.citation | Posterior reversible encephalopathy syndrome associated with deoxycoformycin and alemtuzumab. 2011, 41 (3):215-7 J R Coll Physicians Edinb | en_GB |
| dc.identifier.issn | 2042-8189 | |
| dc.identifier.pmid | 21949916 | |
| dc.identifier.doi | 10.4997/JRCPE.2011.306 | |
| dc.identifier.uri | http://hdl.handle.net/10541/226733 | |
| dc.description.abstract | Posterior reversible encephalopathy syndrome (PRES) is a combined clinical and radiological syndrome characterised by headaches, encephalopathy, seizures and visual loss. We present the case of a 55-year-old male who developed this condition following treatment with deoxycoformycin and alemtuzumab. We review the literature considering diagnosis, pathophysiology and optimal strategies for treatment of this condition. | |
| dc.language.iso | en | en |
| dc.rights | Archived with thanks to The journal of the Royal College of Physicians of Edinburgh | en_GB |
| dc.subject.mesh | Antibodies, Monoclonal, Humanized | |
| dc.subject.mesh | Antibodies, Neoplasm | |
| dc.subject.mesh | Antineoplastic Combined Chemotherapy Protocols | |
| dc.subject.mesh | Humans | |
| dc.subject.mesh | Male | |
| dc.subject.mesh | Pentostatin | |
| dc.subject.mesh | Posterior Leukoencephalopathy Syndrome | |
| dc.title | Posterior reversible encephalopathy syndrome associated with deoxycoformycin and alemtuzumab. | en |
| dc.type | Article | en |
| dc.contributor.department | Department of Critical Care, The Christie, Manchester, UK. cooks199@hotmail.com | en_GB |
| dc.identifier.journal | Journal of the Royal College of Physicians of Edinburgh | en_GB |
| html.description.abstract | Posterior reversible encephalopathy syndrome (PRES) is a combined clinical and radiological syndrome characterised by headaches, encephalopathy, seizures and visual loss. We present the case of a 55-year-old male who developed this condition following treatment with deoxycoformycin and alemtuzumab. We review the literature considering diagnosis, pathophysiology and optimal strategies for treatment of this condition. |